These findings confirm that PGE2 is a potent inducer of IDO1 expression in DCs from leukemia patients similarly to DCs from healthy donors and might result in the induction of some of the tolerogenic effects observed in DC vaccination which are mediated by the immunosuppressive enzyme IDO1. Here, IDO1 is linked to leukemia.